title: Development of acute megakaryoblastic leukemia in Down syndrome is associated with sequential epigenetic changes.
abstract: Acute megakaryoblastic leukemia (AMKL) is more frequently observed in Down syndrome (DS) patients, in whom it is often preceded by a transient myeloproliferative disorder (TMD). The development of DS-TMD and DS-AMKL requires not only the presence of the trisomy 21 but also that of GATA1 mutations. Despite extensive studies into the genetics of DS-AMKL, the importance of epigenetic deregulation in this disease has been unexplored. We performed DNA methylation profiling at different stages of development of DS-AMKL and analyzed the dynamics of the epigenetic program. Early genome-wide DNA methylation changes can be detected in trisomy 21 fetal liver mononuclear cells, prior to the acquisition of GATA1 mutations. These early changes are characterized by marked loss of DNA methylation at genes associated with developmental disorders, including those affecting the cardiovascular, neurological, and endocrine systems. This is followed by a second wave of changes detected in DS-TMD and DS-AMKL, characterized by gains of methylation. This new wave of hypermethylation targets a distinct set of genes involved in hematopoiesis and regulation of cell growth and proliferation. These findings indicate that the final epigenetic landscape of DS-AMKL is the result of sequential and opposing changes in DNA methylation occurring at specific times in the disease development.
authors: Division of Hematology/Oncology, Northwestern University, Chicago, IL;
authors: Sébastien
authors: S
authors: Malinge
authors: Tim
authors: T
authors: Chlon
authors: Louis C
authors: LC
authors: Doré
authors: Rhett P
authors: RP
authors: Ketterling
authors: Martin S
authors: MS
authors: Tallman
authors: Elisabeth
authors: E
authors: Paietta
authors: Alan S
authors: AS
authors: Gamis
authors: Jeffrey W
authors: JW
authors: Taub
authors: Stella T
authors: ST
authors: Chou
authors: Mitchell J
authors: MJ
authors: Weiss
authors: John D
authors: JD
authors: Crispino
authors: Maria E
authors: ME
authors: Figueroa
mesh_terms: D002471:Cell Transformation, Neoplastic / Q000235:genetics*; D019175:DNA Methylation / Q000235:genetics*; D004314:Down Syndrome / Q000150:complications* / Q000235:genetics; D044127:Epigenesis, Genetic / Q000235:genetics*; D006801:Humans; D007947:Leukemia, Megakaryoblastic, Acute / Q000235:genetics*; D009196:Myeloproliferative Disorders / Q000235:genetics
references: Lancet Oncol. 2001 Jul;2(7):429-36
references: 11905737
references: Biostatistics. 2007 Jan;8(1):118-27
references: 16632515
references: Nat Genet. 2009 Nov;41(11):1207-15
references: 19801979
references: Hum Mol Genet. 2007 Apr 1;16(7):774-82
references: 17339268
references: Genet Med. 2001 Mar-Apr;3(2):91-101
references: 11280955
references: Br J Haematol. 2012 Nov;159(3):277-87
references: 22966823
references: Nature. 2008 Jan 3;451(7174):73-5
references: 18172498
references: Blood. 2006 Feb 15;107(4):1570-81
references: 16249385
references: Blood. 2000 Oct 1;96(7):2405-11
references: 11001891
references: Genome Res. 2006 Aug;16(8):1046-55
references: 16809668
references: Methods Mol Biol. 2009;538:395-407
references: 19277580
references: Leukemia. 2004 Oct;18(10):1617-23
references: 15343346
references: Blood. 2012 Apr 19;119(16):3724-33
references: 22383799
references: Bioinformatics. 2008 May 1;24(9):1161-7
references: 18353789
references: Leukemia. 2013 Mar;27(3):731-4
references: 22918081
references: Nat Genet. 1995 Oct;11(2):177-84
references: 7550346
references: Cancer Cell. 2010 Jan 19;17(1):13-27
references: 20060365
references: Blood. 2007 Sep 15;110(6):2128-31
references: 17576817
references: Cancer. 2012 Oct 1;118(19):4806-14
references: 22392565
references: PLoS One. 2008 Mar 26;3(3):e1882
references: 18365023
references: PLoS Genet. 2010 Nov 18;6(11):e1001212
references: 21124956
references: Blood. 2009 Feb 26;113(9):1929-37
references: 19109561
references: Proc Natl Acad Sci U S A. 2006 Feb 28;103(9):3339-44
references: 16492768
references: Br J Haematol. 2004 Jun;125(6):729-42
references: 15180862
references: Blood. 2003 Jun 1;101(11):4301-4
references: 12586620
references: Br J Haematol. 2007 May;137(4):337-41
references: 17456055
references: Proc Natl Acad Sci U S A. 2009 Jul 21;106(29):12031-6
references: 19597142
references: Blood. 2007 Aug 1;110(3):1077-9
references: 17644747
references: Cancer Res. 2002 Mar 1;62(5):1296-9
references: 11888894
references: Blood. 2008 Mar 15;111(6):2991-8
references: 18182574
references: Proc Natl Acad Sci U S A. 1994 May 24;91(11):4997-5001
references: 8197171
references: Eur J Hum Genet. 1993;1(2):114-24
references: 8055322
references: N Engl J Med. 2003 Nov 20;349(21):2042-54
references: 14627790
references: Mol Cell. 2012 Aug 24;47(4):608-21
references: 22771118
references: Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
references: 16199517
references: Blood. 1999 Aug 15;94(4):1393-400
references: 10438727
references: Blood. 2010 Apr 8;115(14):2928-37
references: 20154221
references: Blood. 2008 Nov 15;112(10):4220-6
references: 18755984
references: Blood. 2009 Mar 19;113(12):2619-28
references: 19139078
references: Genes Dev. 2012 Feb 15;26(4):344-9
references: 22345515
references: Blood. 2010 Jan 21;115(3):636-42
references: 19903898
references: Leukemia. 2003 Nov;17(11):2250-2
references: 12931214
references: Cancer Cell. 2006 Jul;10(1):65-75
references: 16843266
references: Br J Haematol. 2000 Sep;110(3):512-24
references: 10997960
references: Blood. 2009 Feb 5;113(6):1315-25
references: 18832655
references: J Clin Invest. 2012 Mar;122(3):948-62
references: 22354171
references: Br J Haematol. 2003 Mar;120(6):930-8
references: 12648061
references: Nucleic Acids Res. 2009 Jul;37(12):3829-39
references: 19386619